GRP
KROS icon

Global Retirement Partners’s Keros Therapeutics KROS Stock Holding History

Global Retirement Partners’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$590 Buy
+29
New +$509 ﹤0.01% 3969
2024
Q4 		$206 Buy
+13
New +$676 ﹤0.01% 3504

Other funds holding KROS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Global Retirement Partners's KROS Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Keros Therapeutics (KROS) in Q4 2025: 29 shares worth $590. The stake represents ﹤0.01% of the portfolio and ranks #3969 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in KROS as recently as Q4 2024.

Global Retirement Partners first reported a position in KROS in Q4 2024 and has held it in 2 quarters since. 166 funds tracked by Wall St. Rank hold KROS as of Q4 2025.

  • Global Retirement Partners held 29 shares of Keros Therapeutics worth $590 as of Q4 2025.
  • Keros Therapeutics was a new Global Retirement Partners position in Q4 2025.
  • Keros Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3969 holding.
  • Global Retirement Partners first reported a position in Keros Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 166 funds tracked by Wall St. Rank held Keros Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.